Prevention of breast cancer in primary care;Prevencion del cancer de mama en atencion primaria

Atencion Primaria

Volumn 26, Issue 6, 2000, Pages 419-427

  Cameselle Teijeiro, J F ^a   Cortizo Torres, M E ^a   Lopez Touza, A ^a   Gomez Cunarro, M ^a   Pousa Estevez, L ^a   Senra Varela, A ^a  

^a HOSPITAL XERAL CALDE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER PREVENTION; HUMAN; PRIMARY MEDICAL CARE; REVIEW; SPAIN; ADULT; BREAST TUMOR; CHEMOPROPHYLAXIS; FEMALE; GENETICS; HEALTH; MASTECTOMY; MIDDLE AGED; PRIMARY HEALTH CARE; PRIMARY PREVENTION;

ADULT; BREAST NEOPLASMS; CHEMOPREVENTION; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; PRIMARY HEALTH CARE; PRIMARY PREVENTION; WORLD HEALTH;

EID: 0033738809     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0212-6567(00)78693-8     Document Type: Article

References (105)

1. Tamoxifen for breast cancer prevention: Ready for prime time?
2. New antiestrogens in breast cancer: A review
3. Tamoxifen: Disease prevention or disease substitution?
4. Quimioprevencion del cancer
5. Position Paper of the American Council on Science and Health on risk factors for breast cancer: Established, speculated and unsupported
6. Prevention
7. Exploracion clinica de la mama y atencion primaria
8. Cancer statistics by race and ethnicity
9. Cancer statistics
10. Breast cancer: Magnitude of the problem and descriptive epidemiology
11. Changing trends: An overview of breast cancer incidence and mortality
12. Tendencia y distribucion geografica de la mortalidad por cancer de mama en Andalucia (1976-1995)
13. Evolution de la mortalite par cancer du sein en Espagne
14. Rising incidence of breast among young women in Sweden
15. Trends in breast cancer incidence and mortality in Denmark 1943-1982
16. Rising incidence of breast cancer among young women in Washington State
17. Cancer de mama. Incidencia y mortalidad en la provincia de Soria
18. El cancer en Tarragona 1980-1985. Estudio epidemiologico descriptivo. Registro de cancer de Tarragona
19. Breast cancer trends: Incidence, mortality and survival
20. La prevencion primaria del cancer
21. Programa de deteccion precoz de cancer de mama en Navarra
22. Directrices para la puesta en marcha y desarrollo de las campanas de deteccion precoz del cancer de mama en Espana
23. Ways that women may possibly reduce their risk of breast cancer
24. Prevention of breast cancer in premenopausal women
25. NCI dietary guidlines: Rationales
26. Ar randomized clinical trial evaluating tamoxifen in the treatment of patients with node negative breast cancer who have estrogen-receptor-positive tumors
27. Adjuvant tamoxifen in the management of operable breast cancer: The Sottish trial
28. Adjuvant tamoxifen in early breast cancer: Ocurrence of new primary
29. Systemic treatment of early breast cancer by hormonal, cytotoxic, or imnune therapy. 133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 comen
30. Tamoxifen for the prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
31. Bioequivalence of 20 mg once-daily tamoxifen relative to 10 mg twice-daily tamoxifen regimens for breast cancer
32. Prophylactic mastectomy
33. Prophylactic mastectomy: Pros and cons
34. Mastectomia subcutanea: Revision de nuestra experiencia en 52 casos
35. Primary breast cancer after prophylactic mastectomy
36. Subcutaneous mastectomy data: A final statistical analysis of 1500 patients
37. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
38. Terapia genica y molecular en la cura del cancer
39. Carcinogenesis humana
40. Chemoprevention of breast cancer
41. The effect of raloxifene on risk of breast cancer in postmenopausal women
42. Who should receive which selective estrogen receptor modulater for prevention of breast cancer?
43. Chemoprevention trial of contralateral breast cancer with fenretidine. Rationales, design, methodology, organization, data management, statistics and accrual
44. Chemoprevention of mammary carcinogenesis by hydroxylated derivatives of d-limonene
45. Prevencion farmacologica del cancer de mama. Revision del tema
46. Quimioprevencion en cancer de mama
47. Selenio y carcinogenesis mamaria
48. Estudio de la actividad proliferativa y grado de diferenciacion del cancer de mama en relacion con los niveles de selenio tisular. Resultados preliminares
49. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
50. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women
51. Soy intake and cancer risk: A review of the in-vitro and in-vivo data
52. International comparisons of mortality rates for cancer of the breast, ovary, prostate and colon per capita food consumption
53. Chemoprevention of rat mammary carcinogenesis: Exceptional actvity of dictary dehydroepiandrosterone (DHEA)
54. Anatomic markers of human premalignancy and risk of breast cancer
55. Morphofunctional features of intraductal hyperplasia, atypical intraductal hyperplasia, and various grades of intraductal carcinoma
56. Cancer de mama familiar, sindromes familiares de cancer y predisposicion al cancer de mama
57. Secondary prevention of cancer: An overview
58. The natural history of breast carcinoma. We have we learned from screening?
59. Some principles of early diagnosis and detection
60. Then to fourteen years effects of breast cancer screening on mortality
61. Screening del cancer de mama. Avances y controversias
62. Seleccion
63. Screening for breast cancer
64. Mammography screening for women over 65
65. Analysis of parenchymal density on mammograms in 1353 women 25-79 years old
66. In screening for breast cancer, clinical examination is as effective as mammography
67. Deteccion de cancer mamario, apego a las indicaciones y valoracion de las lesiones
68. The breast cancer screening controversy: Lessons to be learned
69. Las campanas de despistaje de cancer de mama
70. Screening generalizado versus screening selectivo
71. The effectiveness of breast cancer screening by mammography
72. Efficacy of screening mamography. A meta-analysis
73. Does this patient have breast cancer? The screening clinical breast examination: Should it be done? How?
74. The periodic health examination: 2. 1987 update. Canadian Task Force on the Periodic Health Examination
75. Neoplastic diseases
76. Barreras para la deteccion de cancer
77. Analisis del conocimiento respecto al cancer de mama en la poblacion femenina
78. Modelo de seleccion de mujeres de alto riesgo de cancer de mama
79. Alternativas al cribado poblacional de cancer de mama Es util la deteccion oportunistica?
80. Interaccion de atencion primaria, especializada y paciente en un programa de deteccion precoz del cancer de mama
81. The value of breast self-examination
82. How best to teach women breast self-examination. A randomized controlled trial
83. Breast self-examination among diagnosed breast cancer patients
84. Practica y ensenanza del autoexamen mamario
85. Interim results of a prospective randomized study of self-examination for early detection of breast cancer (Rusia/St.Petersburg/WHO)
86. Principios de oncologia clinica